Position in BIIB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$56,819,242
+$6,323,194 QoQ
Shares Held
262,979
-4.5% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#65
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. BIIB ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,819,242 | 262,979 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $50,496,048 | 275,438 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $47,824,578 | 271,746 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $40,511,976 | 289,206 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $37,695,461 | 300,147 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $40,544,870 | 296,294 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $41,072,935 | 268,591 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $53,172,056 | 274,309 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $65,884,634 | 284,206 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $60,084,005 | 278,644 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $71,950,222 | 278,047 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $71,590,649 | 278,552 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $79,967,649 | 280,736 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $77,787,233 | 279,780 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $77,151,296 | 278,605 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $72,956,682 | 273,246 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $53,669,666 | 263,164 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $52,852,176 | 250,960 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $65,665,864 | 273,699 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $76,246,844 | 269,433 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $94,995,365 | 274,339 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $82,223,280 | 293,917 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $75,778,293 | 309,476 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $100,077,765 | 352,784 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $95,565,916 | 357,189 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $112,478,468 | 355,517 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||